WNT5A and carcinoma: Next, analysis of Wnt/β-catenin signaling components revealed that mRNA expression levels of Wnt5A, CTNNB1P1, DVL1, SMAD4, and JUN were detected in well-differentiated hepatoma but not in their para-carcinoma tissues ().